Skip to main content
. 2023 Jan 11;10:100139. doi: 10.1016/j.lansea.2022.100139

Fig. 4.

Fig. 4

Line plots of GMT (including 95% CIs) of Neutralizing antibodies (nAb) against SARS-Cov-2 - Immunogenicity Analysis Population.